Ipramol Steri-Neb

Ipratropium bromide and salbutamol, the active ingredient in Ipramol Steri-Neb, is a bronchodilator (combination anticholinergic and β2‑adrenergic agonist) presented as an inhalation formulation for inhalation use. It treats bronchospasm associated with asthma, chronic obstructive pulmonary disease (COPD) and acute exacerbations of respiratory disease.

GNH USA supplies Ipramol Steri-Neb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Ipramol Steri-Neb, a combination bronchodilator, is used to manage airway obstruction in several respiratory conditions.

- Asthma: provides rapid relief of bronchospasm and improves airflow. - Chronic obstructive pulmonary disease (COPD): reduces bronchoconstriction and enhances breathing capacity. - Acute exacerbations of respiratory disease: alleviates worsening symptoms and supports recovery.

Ipramol Steri-Neb may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dry mouth: sensation of reduced saliva. - Cough: transient irritation of the airway. - Throat irritation: mild discomfort in the throat. - Tremor: mild shaking of the hands. - Headache: occasional mild headache.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening airway constriction. - Tachycardia: rapid heart rate. - Hypersensitivity reactions: rash, swelling, or anaphylaxis. - Arrhythmias: irregular heart rhythm. - Severe hypotension: marked drop in blood pressure.

When using Ipramol Steri-Neb, consider the following precautions:

- Assess respiratory status: evaluate severity before initiating therapy. - Monitor heart rate: watch for tachycardia especially in patients with cardiac disease. - Use with caution in elderly: increased sensitivity to side effects. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Concomitant β‑agonists: consider additive cardiovascular effects. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Ipramol Steri-Neb can interact with several medicines. Review the following groups before prescribing.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of cardiovascular events. - Tricyclic antidepressants: can potentiate tachycardia. - β‑blockers: may reduce bronchodilator efficacy. - Diuretics: may enhance hypokalemia risk. - Anticholinergic drugs: additive dry mouth.

Moderate Interactions (Monitor Closely): - Theophylline: increased risk of arrhythmias. - Digoxin: possible increased serum levels. - Non‑selective β‑agonists: additive cardiovascular stimulation. - Cough suppressants: may mask bronchospasm symptoms. - Antihistamines: may increase anticholinergic burden.